Dalia Žaliūnienė

A new maximum color contrast sensitivity test for detecting early changes of visual function in age-related macular degeneration

BACKGROUND AND OBJECTIVE To determine the association between age-related macular degeneration (AMD) and color perception established by the Farnsworth-Munsell 100 hue (F-M 100) and maximum color contrast sensitivity (MCCS) tests. MATERIALS AND METHODS We performed a case-control study, which comprised of 100 patients with AMD and 100 healthy controls. To test visual acuity (VA), a typical Snellen chart was used. The computerized F-M 100 and MCCS programs were used for color discrimination. RESULTS The results of VA, and the F-M 100 and MCCS tests in the healthy controls were statistically significantly better than in the patients with AMD (1.0 vs. 0.82±0.16, P=0.005; 87.39±24.11 vs. 185.39±74.43, P=0.005; 1.33±1.17 vs. 1.96±0.46, P=0.005, respectively). When VA was 1.0 in patients with AMD, the total error scores of the F-M 100 test and MCCS test compared with healthy persons were even worse (166.09±66.57 vs. 87.39±24.11, P=0.002; 1.67±0.92 vs. 1.33±1.17, P=0.001, respectively). Analysis of the results of patients with AMD compared to healthy controls showed the highest error score in the blue color range. CONCLUSIONS The results of the color contrast sensitivity test decreased by half in patients with AMD compared with ophthalmologically healthy patients when they performed the F-M 100 test and by one and half when they performed a MCCS test in the blue color range.

ABO blood group polymorphism has an impact on prostate, kidney and bladder cancer in association with longevity

The aim of the present study was to assess the ABO blood group polymorphism association with prostate, bladder and kidney cancer, and longevity. The following data groups were analyzed: Prostate cancer (n=2,200), bladder cancer (n=1,530), renal cell cancer (n=2,650), oldest-old (n=166) and blood donors (n=994) groups. The data on the ABO blood type frequency and odds ratio in prostate cancer patients revealed a significantly higher blood group B frequency (P<0.05); the pooled men and women, separate men bladder cancer risk was significantly associated with the blood group B (P<0.04); however, no such association was identified in the female patients. The blood group O was observed to have a significantly decreased risk of bladder cancer for females (P<0.05). No significance for the ABO blood group type in the studied kidney cancer patients was identified. A comparison of the oldest-old and blood donor groups revealed that blood group A was significantly more frequent and blood type B was significantly rarer in the oldest-olds (P<0.05). The results of the present study indicated that blood type B was associated with the risk of prostate and bladder cancer, and could be evaluated as a determinant in the negative assocation with longevity. Blood types O and A may be positive factors for increasing the oldest-old age likelihood. The clustering analysis by the ABO type frequency demonstrated that the oldest-olds comprised a separate cluster of the studied groups.

The role of MMP-1 and FGFR4-R388 gene polymorphisms in pituitary adenoma

Background. The pathogenesis of pituitary adenoma (PA) is complex and poorly understood. It is thought that PA has a multifactorial aetiology; genetic factors also have an impact on PA development. Since MMP1 and FGFR4 genes play an important role in tumour growth, differentiation and progression, we decided to determine if the frequency of the genotypes of MMP-1 and FGFR4-R388 polymorphisms influence the development of PA. Materials and methods. The study enrolled n = 100 patients with PA and n = 200 healthy controls (reference group). The genotyping tests of MMP-1 and FGFR4-R388 were carried out using the real-time polymerase chain reaction (PCR) method. Results. The polymorphism in the MMP-1 gene 1G/1G genotype was more frequent in the group of invasive PA than in the control group: 28.6% vs. 16.5%, p = 0.044. The 1G/2G genotype was more frequent in females of the control group compared to PA group females: 50.3% vs. 30.8%, p = 0.011. The polymorphism in the MMP-1 gene 1G/1G genotype was more frequent in the active PA group than in the control group: 28.4% vs. 16.5%, p = 0.044. FGFR4-R388 did not play any predominant role in PA development. Conclusion. The MMP-1 gene 1G/1G may play a role in invasive and active PA development.

N-carboxymethyllysine as a biomarker for coronary artery disease and age-related macular degeneration

BACKGROUND AND OBJECTIVE An association between coronary artery disease (CAD) and age-related macular degeneration (ARMD) has long been postulated, but exact mechanisms remain unclear. The global prevalence of CAD and ARMD increases and early biomarkers for early diagnosis of these diseases are necessary. The aim of this study was to investigate the plasma level of oxidative stress biomarker CML in patients with and without angiographic findings of atherosclerosis in the coronary arteries (CADath+ and CADath-, respectively) and to assess if there was an association of CAD with ARMD. MATERIALS AND METHODS The study enrolled 233 subjects. Based on cardiologic and ophthalmologic examinations, the patients were divided into four subgroups: CADath+ARMD+, CADath+ARMD-, CADath-ARMD+, and CADath-ARMD-. The enzyme-linked immunosorbent assay was used for the measurement of plasma CML levels. Serum lipid levels were determined by an automatic analyzer using conventional enzymatic methods. RESULTS CADath+ patients had higher CML concentration compared to CADath- subjects (1.04±0.6 vs. 0.83±0.4ng/mL, P<0.001). The highest mean CML level (1.12±0.7ng/mL) was found in CADath+ARMD+ patients. The mean plasma CML concentration was higher in subjects with any of the analyzed diseases compared to CADath-ARMD- subjects. A significant positive association of CADath+ (OR=2.50, 95% CI 1.60-3.90, P=0.0001), ARMD (OR=2.08, 95% CI 1.40-3.11, P=0.0001) and both analyzed diseases (OR=4.67, 95% CI 2.29-9.53, P=0.0001) with an increased level of plasma CML in a logistic regression model adjusting by age was identified. CONCLUSIONS The level of CML, an oxidative stress biomarker, reflects the presence of atherosclerosis in coronary arteries and shows a possible link between ARMD and CADath+ via oxidative status.

Regos nervo disko drūzų sąsajos su spalvų jusle

Tyrimo tikslas. Nustatyti ribinio spalvinio kontrastinio jautrumo ir Munsell-Farnsworth 100 atspalvių atrinkimo tyrimų rodmenų ir regėjimo astrumo sąsajas, esant regos nervo disko drūzų. Tyrimo medžiaga ir metodai. Atliktas 137 pacientų atvejo–kontrolės tyrimas. Istirti 37 pacientai (67 akys), kuriems diagnozuotos regos nervo disko drūzos ir 100 sveikų žmonių (200 akių) kontrolinė grupė. Nekoreguotas ir geriausias koreguotas regėjimo astrumas vertintas naudojant Landolto žiedus (C optotipais), pagal Sneleno principą. Spalvinio kontrastinio jautrumo tyrimui naudoti kompiuteriniai Farnsworth-Munsell 100 atspalvių ir ribinio spalvinio kontrastinio jautrumo tyrimai. Rezultatai. Kontrolinės grupės tiriamųjų, ribinis spalvinis kontrastinis jautrumas ir Farnsworth- Munsell 100 atspalvių atrinkimo tyrimo rezultatai buvo geresni nei pacientų (1,94±0,66 palyginti su 2,2±0,85, p=0,02; 94,1±53,9 palyginti su 120,6±61, p=0,003, atitinkamai). Isvada. Tyrimo duomenimis, regos nervo disko drūzos susijusios su spalvų juslės sumažėjimu.